Arnold J. Levine Becomes Eighth President of The Rockefeller University.

Arnold J. Levine, one of the world’s leading cancer researchers, officially became the eighth president of The Rockefeller University at the university’s board meeting on Wed., Dec. 2. Levine, who was elected president in June 1998, succeeds Torsten N. Wiesel, who is retiring after seven years of service as Rockefeller’s president. More »

Tags: ,

Rockefeller Researchers Show First Evidence for Naturally Occurring Tumor Immunity in Humans

A team of researchers from The Rockefeller University have now shown for the first time that humans are able to develop naturally occurring immunity to cancer. The study, reported in the November issue of Nature Medicine, provides support for the recent efforts to treat cancer patients by activating their immune response in a manner that would lead to tumor immunity, a treatment called immunotherapy. An understanding of naturally occurring tumor immunity is important for the development of better strategies to treat cancer. More »

Tags: , , ,

Mariellen Gallagher Joins Rockefeller University as Vice President for Communications and Public Affairs

Mariellen Gallagher, who has handled external affairs for three major universities, has been appointed vice president for communications and public affairs at The Rockefeller University. The announcement was made jointly by Arnold Levine, Ph.D., the president-elect of The Rockefeller University, and Torsten N. Wiesel, M.D., the current president. More »

Tags: , ,

Structure of Enzyme Involved in Gentamicin Resistance Revealed for First Time

A team of scientists, led by researchers from the Howard Hughes Medical Institute (HHMI) at The Rockefeller University, has determined the three-dimensional structure of an enzyme responsible for resistance of certain bacteria to the antibiotic gentamicin. The structure, reported in the August 21 Cell, is the first for this family of antibiotics and presents a possible target for designing drugs to thwart resistance. More »

Tags: , ,

Subtle Changes in Brain Receptor Gene May Have Significant Consequences for Addiction

Scientists have identified five slightly different versions of the mu opioid receptor gene that alter the activity of a molecule called b-endorphin, a member of the endorphin family of proteins that can numb pain, create feelings of euphoria or increase energy, which opiates and other drugs of analgesia and addiction do as well. The findings, reported by researchers from The Rockefeller University, Indiana University School of Medicine and University of Cincinnati College of Medicine in the August 4 Proceeding of the National Academy of Sciences, show for the first time that these altered molecules are distributed differently among ethnic groups and have implications for normal physiology, therapeutics and vulnerability to develop or protect from diverse diseases involving mu opioid receptors, including the addictive diseases. More »

Tags: , , ,

Scientists Track Spread of Antibiotic-Resistant Bacteria in 12 New York City Hospitals

A team of researchers led by scientists from The Rockefeller University and the Public Health Research Institute (PHRI) used molecular fingerprinting techniques to track the spread of methicillin-resistant Staphylococcus aureus (MRSA) in 12 hospitals in the New York City metropolitan area. The findings, published in the July issue of the Journal of Infectious Diseases, confirms the prevalence of antibiotic-resistant strains of staph in New York City. More »

Tags: , , ,

Scientists Identify New Gene That Controls Sleep/Wake Cycle

A newly discovered gene called double-time regulates the molecular cycles underlying circadian rhythms, scientists from The Rockefeller University report in two papers featured on the cover of the July 10 issue of Cell. The researchers also identified the molecular mechanism that allows this gene to work. More »

Tags: , ,

Arnold J. Levine Named President of Rockefeller University

Dr. Arnold J. Levine, the Harry C. Wiess Professor in the Life Sciences at Princeton University and a world-renowned cancer biologist, has been elected the eighth president of The Rockefeller University. Dr. Levine was selected to succeed Dr. Torsten N. Wiesel, who will retire this fall after seven years of service as Rockefeller’s president. Levine will assume the presidency after the regularly scheduled November board of trustees meeting. More »

Tags: ,

Lewis Thomas Prize Honors Ernst Mayr

Evolutionary biologist and author Ernst Mayr, Ph.D., is the recipient of the 1998 Lewis Thomas Prize: Honoring the Scientist as Poet. The prize, which honors scientists for their literary achievements, is awarded by The Rockefeller University. More »

Tags: ,

Rockefeller University Researchers Hunt for Type 2 Diabetes Susceptibility Genes

The Rockefeller University is looking for people with type 2 diabetes to participate in a study aimed at determining the genetic causes of early- and late-onset forms of the disease. The study is part of the research program of the university’s Starr Center for Human Genetics. More »

Tags: , , ,

Researchers from Rockefeller University Develop Novel Method to Fight Cancer

Researchers from The Rockefeller University in New York City have developed a new method to fight cancer by using dendritic cells to activate T cells via a new pathway. Reported in the March 5 Nature, the technique offers the promise of new therapies for cancer, AIDS and autoimmune diseases. More »

Tags: , , ,

Rockefeller University Creates Center for Immune Disease Research

The Rockefeller University will launch the Christopher H. Browne Center for Immunology and Immune Diseases with a $5 million gift from university Trustee Christopher H. Browne, managing director of the investment firm Tweedy Browne Company, LLC. The center will provide immunologists at the university with access to the next generation of sophisticated laboratory technologies, speeding the progress of research on a broad spectrum of diseases that involve the immune system, including cancer, AIDS and other infectious diseases, and such autoimmune disorders as arthritis, asthma, diabetes, and lupus. More »

Tags: ,

From the Center for the Advancement of Health: Stress: It’s Not Just All in Your Head

Please refer to the following link:


Chemistry Magazine Names Rockefeller Nobel Laureate One of 75 Top Chemists

Nobel Prize winner Bruce Merrifield, Ph.D., John D. Rockefeller Jr. Professor Emeritus at The Rockefeller University, has been named one of the top 75 “distinguished contributors to the chemical enterprise” by Chemical & Engineering News (C&EN), the news magazine of the American Chemical Society, in a special issue marking the society’s 75th anniversary.
More »

Tags: , ,

Glucose metabolism defect in rare form of Type 2 diabetes revealed

A defect in a gene recently linked to a rare inherited form of Type 2 diabetes impairs the pathway that breaks down blood sugar and provides the main signal for insulin secretion in the pancreas, report researchers at The Rockefeller University in the Nov. 25 Proceedings of the National Academy of Sciences. This work provides the first insight into the molecular mechanism of this disease and opens new avenues for developing better therapies to treat more common forms of late-onset diabetes. More »

Tags: , , , ,

Plant-Based Therapies Examined for Colon Cancer Prevention

Three therapies derived from plants will be tested at The Rockefeller University in New York City for their ability to prevent colorectal cancer, which afflicts some 150,000 Americans each year. The compounds have the potential to be safer than cancer-thwarting nonsteroidal antiinflammatory drugs (NSAIDs), widely used aspirin-like drugs known to prevent colorectal cancer as well as reduce related deaths by half. More »

Tags: , , ,

Hunt for Early Heart Attack Genes Begins

More than 2,000 people will be enrolled in a hunt for the genetic causes that underlie “early” heart attacks that strike men and women in middle age. The study is part of the research program of the Starr Center for Human Genetics at The Rockefeller University in New York City. More »

Tags: , , ,

Mutated Gene Causes Death of Nerves in Brain

A gene responsible for the degeneration and death of certain nerve cells in the brain has been cloned, yielding information that may be useful for further studies of such neurodegenerative diseases as Alzheimer’s and Parkinson’s, investigators from the Howard Hughes Medical Institute at The Rockefeller University and from The Johns Hopkins School of Medicine report in the Aug. 21 Nature. More »

Tags: , , ,

Resistance to Leptin Contributes to Obesity

Insensitivity to the protein leptin, which helps the body regulate its fat stores, contributes to obesity in mice according to the first formal study of leptin intolerance, report scientists in the Aug. 5 Proceedings of the National Academy of Sciences. The findings also provide clues about leptin’s action in the nervous system and may help to explain some forms of obesity that affect humans, including more than 50 million overweight adult Americans, the researchers note. More »

Tags: ,

Rockefeller University Honors William O. Baker, Presents Honorary Degrees to Irene Diamond and Christian de Duve and Awards 21 Doctorates at Graduation Ceremonies

The Rockefeller University will honor William O. Baker, Ph.D., former chairman of the board of AT&T Bell Laboratories, Inc., and award honorary doctoral degrees to philanthropist Irene Diamond and Nobel Prize winner Christian de Duve, Ph.D., M.D., at the institution’s 39th commencement exercises, Thursday, June 12, 1997. More »

Tags: ,